References
- Haritos AA, Goodall GJ, Horecker BL, et al. Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1008–1011. PubMed PMID: 6583693; PubMed Central PMCID: PMCPmc344752. eng.
- Manjula BN, Trus BL, Fischetti VA, et al. Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1064–1068. PubMed PMID: 3856248; PubMed Central PMCID: PMCPmc397194. eng.
- Mosoian A, Teixeira A, Burns CS, et al. Influence of prothymosin-alpha on HIV-1 target cells. Ann N Y Acad Sci. 2007 Sep;1112:269–285. PubMed PMID: 17600282; eng. DOI:10.1196/annals.1415.043
- Samara P, Ioannou K, Tsitsilonis OE, et al. Prothymosin alpha and immune responses: are we close to potential clinical applications? Vitam Horm. 2016;102:179–207. PubMed PMID: 27450735; eng. DOI:10.1016/bs.vh.2016.04.008
- Ueda H, Fujita R, Yoshida A, et al. Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J Cell Biol. 2007 Mar 12;176(6):853–862. PubMed PMID: 17353361; PubMed Central PMCID: PMCPmc2064059. eng. DOI:10.1083/jcb.200608022
- Mosoian A, Teixeira A, Burns CS, et al. Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178–10183. PubMed PMID: 20479248; PubMed Central PMCID: PMCPmc2890444. eng. DOI:10.1073/pnas.0914870107
- Omotuyi O, Matsunaga H, Ueda H, et al. Evidence for ProTalpha-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies. Expert Opin Biol Ther. 2015;15(Suppl 1):S223–9. PubMed PMID: 25604147; eng. DOI:10.1517/14712598.2015.1005597
- Halder SK, Matsunaga H, Ishii KJ, et al. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina. J Neurochem. 2015 Dec;135(6):1161–1177. PubMed PMID: 26364961; eng. DOI:10.1111/jnc.13356
- Fujita R, Ueda M, Fujiwara K, et al. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ. 2009 Feb;16(2):349–358. PubMed PMID: 18989338; eng.
- Freeman KW, Bowman BR, Zetter BR, et al. Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB J. 2011 Mar;25(3):907–915. PubMed PMID: 21106936; eng.
- Maeda S, Sasaki K, Halder SK, et al. Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages. J Pharmacol Sci. 2016 Sep;132(1):100–104. PubMed PMID: 27543170; eng. DOI:10.1016/j.jphs.2016.05.006
- Ueda H, Matsunaga H, Uchida H, et al. Prothymosin alpha as robustness molecule against ischemic stress to brain and retina. Ann N Y Acad Sci. 2010 Apr;1194:20–26. PubMed PMID: 20536446; eng. DOI:10.1111/j.1749-6632.2010.05466.x
- Macdonald JL, Pike LJ. A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res. 2005 May;46(5):1061–1067. PubMed PMID: 15722565; eng. DOI:10.1194/jlr.D400041-JLR200
- Leyva JA, Bianchet MA, Amzel LM, et al. Understanding ATP synthesis: structure and mechanism of the F1-ATPase (Review). Mol Membr Biol. 2003 Jan–Mar;20(1):27–33. PubMed PMID: 12745923; eng.